% alzhub.org library filter % Source: https://alzhub.org/research?author=Greig+NH&atag=agonists % 11 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{kim2017-29113464, author = {Kim, D. S. and Choi, H. I. and Wang, Y. and Luo, Y. and Hoffer, B. J. and Greig, N. H.}, title = {{A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway}}, journal = {Cell transplantation}, year = {2017}, doi = {10.1177/0963689717721234}, pmid = {29113464}, url = {https://doi.org/10.1177/0963689717721234} } @article{bassil2017-28334990, author = {Bassil, F. and Canron, M. H. and Vital, A. and Bezard, E. and Li, Y. and Greig, N. H. and Gulyani, S. and Kapogiannis, D. and others}, title = {{Insulin resistance and exendin-4 treatment for multiple system atrophy}}, journal = {Brain : a journal of neurology}, year = {2017}, doi = {10.1093/brain/awx044}, pmid = {28334990}, url = {https://doi.org/10.1093/brain/awx044} } @article{kopp2022-36372278, author = {Kopp, K. O. and Glotfelty, E. J. and Li, Y. and Greig, N. H.}, title = {{Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment}}, journal = {Pharmacological research}, year = {2022}, doi = {10.1016/j.phrs.2022.106550}, pmid = {36372278}, url = {https://doi.org/10.1016/j.phrs.2022.106550} } @article{perry2002-12183643, author = {Perry, T. and Haughey, N. J. and Mattson, M. P. and Egan, J. M. and Greig, N. H.}, title = {{Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4}}, journal = {The Journal of pharmacology and experimental therapeutics}, year = {2002}, doi = {10.1124/jpet.102.037481}, pmid = {12183643}, url = {https://doi.org/10.1124/jpet.102.037481} } @article{perry2003-12749025, author = {Perry, T. and Lahiri, D. K. and Sambamurti, K. and Chen, D. and Mattson, M. P. and Egan, J. M. and Greig, N. H.}, title = {{Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron}}, journal = {Journal of neuroscience research}, year = {2003}, doi = {10.1002/jnr.10611}, pmid = {12749025}, url = {https://doi.org/10.1002/jnr.10611} } @article{perry2002-11861804, author = {Perry, T. and Lahiri, D. K. and Chen, D. and Zhou, J. and Shaw, K. T. and Egan, J. M. and Greig, N. H.}, title = {{A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells}}, journal = {The Journal of pharmacology and experimental therapeutics}, year = {2002}, doi = {10.1124/jpet.300.3.958}, pmid = {11861804}, url = {https://doi.org/10.1124/jpet.300.3.958} } @article{salcedo2012-22519295, author = {Salcedo, I. and Tweedie, D. and Li, Y. and Greig, N. H.}, title = {{Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders}}, journal = {British journal of pharmacology}, year = {2012}, doi = {10.1111/j.1476-5381.2012.01971.x}, pmid = {22519295}, url = {https://doi.org/10.1111/j.1476-5381.2012.01971.x} } @article{perry2005-15974903, author = {Perry, T. and Greig, N. H.}, title = {{Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease}}, journal = {Current Alzheimer research}, year = {2005}, doi = {10.2174/1567205054367892}, pmid = {15974903}, url = {https://doi.org/10.2174/1567205054367892} } @article{perry2004-15270203, author = {Perry, T. A. and Greig, N. H.}, title = {{A new Alzheimer's disease interventive strategy: GLP-1}}, journal = {Current drug targets}, year = {2004}, doi = {10.2174/1389450043345245}, pmid = {15270203}, url = {https://doi.org/10.2174/1389450043345245} } @article{rachmany2013-22892942, author = {Rachmany, L. and Tweedie, D. and Li, Y. and Rubovitch, V. and Holloway, H. W. and Miller, J. and Hoffer, B. J. and Greig, N. H. and others}, title = {{Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice}}, journal = {Age (Dordrecht, Netherlands)}, year = {2013}, doi = {10.1007/s11357-012-9464-0}, pmid = {22892942}, url = {https://doi.org/10.1007/s11357-012-9464-0} } @article{perry2002-12515900, author = {Perry, T. and Greig, N. H.}, title = {{The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2002}, doi = {10.3233/jad-2002-4605}, pmid = {12515900}, url = {https://doi.org/10.3233/jad-2002-4605} }